Primitive Neuroectodermal Tumor: Clinical Trials

1 trial for Primitive Neuroectodermal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Primitive Neuroectodermal Tumor: new trials by email Literature Review of Primitive Neuroectodermal Tumor trials Research Report on Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
Antineoplaston therapy (Atengenal + Astugenal) - Primitive Neuroectodermal Tumor
Phase 2TerminatedBurzynski Research Institute11996-12-122017-09-29

Narrower conditions

Neuroectodermal Tumors, Primitive (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Interventions

antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)

Sponsors

Burzynski Research Institute (1)

Countries

United States (1)

Top investigators

Stanislaw R. Burzynski, MD, PhD (1)